本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

TG Therapeutics Inc.

32.00
-0.3800-1.17%
盘后31.99-0.0100-0.03%19:56 EDT
成交量:162.10万
成交额:5,161.56万
市值:50.77亿
市盈率:134.38
高:32.29
开:32.12
低:31.48
收:32.38
52周最高:46.48
52周最低:21.16
股本:1.59亿
流通股本:1.48亿
量比:0.60
换手率:1.10%
股息:- -
股息率:- -
每股收益(TTM):0.2381
每股收益(LYR):0.1609
净资产收益率:26.63%
总资产收益率:9.72%
市净率:18.37
市盈率(LYR):198.87

数据加载中...

2025/08/08

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/04

重要事件披露

Form 8-K - Current report
2025/06/13

重要事件披露

Form 8-K - Current report
2025/06/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/05

重要事件披露

Form 8-K - Current report
2025/03/03

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/03

重要事件披露

Form 8-K - Current report
2025/01/14

重要事件披露

Form 8-K - Current report
2025/01/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/04

重要事件披露

Form 8-K - Current report
2024/08/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/09

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]